Adverse reactions to plasma products
Although plasma products can save lives, their use is not without risk. In some cases there can be adverse reactions, which can differ in severity.
Adverse reactions that you could experience after you receive a plasma transfusion include:
- a slight rise in temperature
- itching and sometimes a rash (hives) – this can occur within a few minutes of starting to receive a plasma transfusion, but can usually be cured by slowing down the rate of transfusion or by taking an antihistamine (medication to treat mild allergic reactions)
The risk of developing an infection after receiving plasma is very small. All blood donations used to make plasma have to be carefully screened for viruses to make sure they are safe.
However, as is the case with most medical procedures, there are possible risks associated with receiving plasma. Some of these are briefly outlined below.
Transfusion-related acute lung injury (TRALI)
Transfusion-related acute lung injury (TRALI) is a reaction that can occasionally occur in someone who receives a plasma transfusion. During or shortly after the transfusion the person will have breathing difficulties, which can sometimes be severe.
The reaction is thought to occur because the donated plasma contains antibodies (proteins produced by the donor's immune system), called HLA antibodies, that react with the recipient's white blood cells. This occurs more often when plasma has been donated by a female donor who has had pregnancies in the past and whose immune system produced the antibodies as a response to pregnancy.
Antibodies are normally produced by the immune system to fight organisms in the blood that the body regards as 'foreign', such as bacteria, but in pregnancy they have a protective role.
To minimise the risk of TRALI, plasma from male donors is usually used to make fresh frozen plasma (FFP) and other plasma-containing blood products used for transfusion.
Fractionated plasma products do not cause TRALI.
Variant Creutzfeldt-Jakob disease (vCJD)
Variant Creutzfeldt-Jakob disease (vCJD) is the human form of bovine spongiform encephalopathy (BSE), commonly known as mad cow disease. First identified in 1996, vCJD is a rare neurological illness that causes brain damage. It occurs as a result of eating the meat of cattle infected with BSE.
The risk of developing vCJD after having a blood transfusion is very small, but there is currently no test available to screen blood for the prion protein that causes vCJD.
However, to minimise the risk further, the NHS has put a number of precautions in place. These include:
- removing all white cells by filtering cellular blood components (red blood cells and platelets)
- importing fresh frozen plasma from countries where there have been no cases of vCJD for transfusion to those born after January 1 1996
- using pooled plasma for fractionation from countries where there have been no cases of vCJD and using recombinant clotting factors (produced in a laboratory using DNA technology) for treating haemophiliacs, where these products are available
- only using plasma transfusions when absolutely necessary
Read more about
How plasma and plasma-products are used
Plasma and plasma products can be removed from blood in a number of different ways, allowing them to be used to treat a variety of conditions.
The main ways that plasma is used include:
- plasma transfusions
- plasma exchange (plasmapheresis)
Plasma products can be used to help prevent health problems occurring in conditions such as
Plasma can also be given as a transfusion when a patient has lost a lot of blood.
To obtain plasma for transfusion, a donation containing all the components of blood (whole blood), including plasma, is taken from one person. The plasma is then separated from the red cells and frozen, becoming fresh frozen plasma (FFP). When needed, it is thawed and given as a transfusion to another person.
For example, a patient may be given a plasma transfusion if they are bleeding after a serious accident or following major surgery where clotting factors need replacing as well as red blood cells.
Before someone is able to donate blood for transfusion, they have to comply with a strict set of guidelines about their medical, travel and sexual history. This ensures it is safe for them to donate and that their blood is safe to be transfused. As with whole blood, plasma is always checked for viruses to make sure it is as safe as possible to use.
Plasma transfused to patients born after January 1 1996 comes from donors outside the UK, to reduce the risk of
Read more about
Plasma products made by fractionation
Many of the components found in plasma can be separated and removed so they can be used to treat specific problems.
A number of plasma donations are mixed (pooled) and then subjected to a number of different heat and chemical treatments, before the various proteins are separated out in a complex process known as fractionation. Fractionation can take up to five days.
All blood donations used to make plasma pools for fractionation have to be checked for viruses to make sure they are as safe as possible to use. In addition, the pooled plasma is carefully filtered and 'cleaned' using heat, detergents and solvents to remove any viruses that may be present.
After the fractionation process has been completed, the plasma products are either kept as a liquid or freeze-dried as a powder for reconstitution before use. They are then packaged, ready for distribution to clinics, surgeries and hospitals.
Some patients, such as those with haemophilia, have their own supply of plasma products so they are able to treat themselves at home.
There are numerous plasma products, but the three main ones are:
- human albumin solution
- clotting (coagulation) factors
- normal human immunoglobulin
Plasma exchange, also known as plasmapheresis, is a procedure where a machine called a cell separator is used to separate plasma from the other components of a patient’s blood.
During the procedure, the plasma is removed and replaced with a substitute (usually human albumin solution) and the red cells, white cells and platelets are returned to the patient.
Plasma exchange is often used to treat rare blood conditions. Some of these are briefly outlined below.
Thrombotic thrombocytopenic purpura
Thrombotic thrombocytopenic purpura is a rare clotting disorder affecting the platelets, where microscopic blood clots form and damage organs and red blood cells.
Plasma exchange separates and removes the plasma from the rest of the blood and replaces it with frozen plasma. This replenishes levels of a vital enzyme that controls the platelet clotting and removes the antibodies responsible for the condition.
Multiple myeloma and Waldenström's macroglobulinaemia
If the protein levels in the blood become too high, the blood can thicken, which is known as hyperviscosity. The symptoms of hyperviscosity include:
- fatigue (tiredness)
- blurred vision
Plasma exchange reduces the amount of abnormal protein in the blood, which helps relieve the symptoms. However, the process does not prevent the production of immunoglobulin. Other treatments, such as
Plasma exchange procedure
During plasma exchange, a machine called a cell separator is used to separate the plasma from the rest of the blood. A needle is inserted into a vein in the arm and the blood is removed and passed through the cell separator.
The plasma is separated from the rest of your blood and a plasma substitute added, before the blood is returned through a needle in a vein in the other arm.
Plasma exchange takes about two hours to perform. During the process, only a small amount of blood (less than 100ml) will be outside the body at any one time. This is because the blood is being removed and returned at the same rate.
The amount of plasma exchanged will depend on factors such as:
- your height
- your weight
- how viscous (thick) your blood is
The number of plasma exchanges needed will depend on your symptoms and how well you are responding to your other treatments.
Faintness and lightheadedness are both possible side effects of a plasma exchange. If you feel faint or lightheaded you should tell the healthcare professional treating you. The symptoms can usually be effectively treated by changing to a lying down position. Ensuring you have something to eat on the day of the procedure will also help prevent these symptoms.
During a plasma exchange, you may also experience numbness or a tingling sensation around your nose and mouth and in your fingers. This is caused by a substance called citrate, which is added to your blood as it goes through the machine to prevent it clotting. The citrate may affect the levels of calcium in your blood.
Let the healthcare professional treating you know if you experience numbness or tingling sensations. They may stop the plasma exchange for a few minutes until your body adjusts to the increased citrate levels in your blood, or they may increase the level of calcium in your blood.
What is plasma?
Plasma is the fluid part of blood and makes up most of the volume. It contains substances that can be used to treat different conditions.
Blood is made up of four elements, which each perform a different function:
- red blood cells – these carry oxygen around the body and remove carbon dioxide
- white blood cells – these help the body fight infection
- platelets – these tiny cell fragments trigger the process that causes the blood to clot (thicken)
- plasma – this yellow fluid transports blood cells and platelets around the body and contains a number of substances, including proteins
What is plasma?
Plasma is the largest component of blood, making up about 55% of its overall content. It is mainly made up of water and surrounds the blood cells, carrying them around the body.
Plasma also stores body fluids, helps maintain blood pressure and regulates body temperature. It contains a complex mix of substances used by the body to perform important functions. These substances include:
Three important proteins are found in plasma:
- clotting (coagulation) factors
Uses of plasma products
The following plasma products can be used to treat a variety of different conditions.
Albumin cleans the blood, carries substances around the body and helps to maintain the correct amount of fluid circulating in the body.
Human albumin solution can be used as a treatment to help people with severe burns, or with liver or
Clotting (coagulation) substances, called factors, help to control bleeding and work together with blood platelets to ensure that the blood clots effectively.
Fresh frozen plasma and clotting factors can be used to treat blood clotting disorders such as
Immunoglobulins are part of the immune system (the body’s natural defence against illness and infection).
Immunoglobulins are antibodies that the body produces to fight unwanted viruses and bacteria. For example, they are used to fight health conditions such as:
Normal human immunoglobulins can be used to support people who are having cancer treatment when their immune system is having difficulty producing antibodies.
Plasma is the source of anti-D immunoglobulin, a substance often given by injection to pregnant women with a rhesus negative blood group (RhD negative) and whose unborn baby may have a rhesus positive blood group (RhD positive).
This treatment prevents the mother becoming sensitised to the baby’s blood and stops immune anti-D developing. Immune anti-D can cause
How are plasma products used?
Plasma products can be used in a number of different ways, depending on the condition they are being used to treat.
The main uses of plasma products include:
- fresh frozen plasma transfusion – plasma is separated from donated blood and frozen until needed, it is then thawed under controlled conditions and transfused to the recipient
- plasma exchange – a special machine is used to remove plasma from the blood, the plasma is then replaced with a substitute plasma product
- fractionation – removed plasma is treated to separate it into different proteins, these can then be used to treat certain conditions
Read more about
Risks of using plasma products
Some people can experience further problems after a plasma transfusion.
These can vary in severity from a slight temperature rise, to the development of variant Creutzfeldt-Jakob disease (vCJD) in very rare cases.
Read more about